110 related articles for article (PubMed ID: 26329991)
1. Drug reaction with eosinophilia and systemic symptoms: a clinicopathological study of six cases at a teaching hospital in midwestern Brazil.
Correa-de-Castro B; Paniago AM; Takita LC; Murback ND; Hans-Filho G
Int J Dermatol; 2016 Mar; 55(3):328-34. PubMed ID: 26329991
[No Abstract] [Full Text] [Related]
2. Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases.
Skowron F; Bensaid B; Balme B; Depaepe L; Kanitakis J; Nosbaum A; Maucort-Boulch D; Bérard F; D'Incan M; Kardaun SH; Nicolas JF
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2199-205. PubMed ID: 26354734
[TBL] [Abstract][Full Text] [Related]
3. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
[TBL] [Abstract][Full Text] [Related]
4. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient.
Bayram AK; Canpolat M; Çınar SL; Tahan F; Gumus H; Kumandaş S; Per H
J Emerg Med; 2016 Feb; 50(2):e61-6. PubMed ID: 26597350
[TBL] [Abstract][Full Text] [Related]
5. Drug reaction with eosinophilia and systemic symptoms syndrome.
Spriet S; Banks TA
Allergy Asthma Proc; 2015; 36(6):501-5. PubMed ID: 26534757
[TBL] [Abstract][Full Text] [Related]
6. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
Matsuda H; Saito K; Takayanagi Y; Okazaki T; Kashima K; Ishikawa K; Kai Y; Takeo N; Hatano Y; Okamoto O; Fujiwara S
J Dermatol; 2013 Feb; 40(2):118-22. PubMed ID: 23216243
[TBL] [Abstract][Full Text] [Related]
7. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19.
Ramirez GA; Della-Torre E; Tresoldi M; Scarpellini P; Ciceri F; Dagna L; Yacoub MR
Clin Microbiol Infect; 2021 Aug; 27(8):1190-1192. PubMed ID: 34015530
[No Abstract] [Full Text] [Related]
8. The serum level of HMGB1 (high mobility group box 1 protein) is preferentially high in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Fujita H; Matsukura S; Watanabe T; Komitsu N; Watanabe Y; Takahashi Y; Kambara T; Ikezawa Z; Aihara M
Br J Dermatol; 2014 Dec; 171(6):1585-8. PubMed ID: 24903194
[No Abstract] [Full Text] [Related]
9. TNF-α as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS).
Uno H; Kabashima K; Tohyama M; Watanabe T; Hashimoto K; Iijima M; Sueki H; Watanabe H
J Dermatol Sci; 2014 May; 74(2):177-9. PubMed ID: 24517870
[No Abstract] [Full Text] [Related]
10. DRESS Syndrome: Drug Reaction With Eosinophilia and Systemic Symptoms.
Corneli HM
Pediatr Emerg Care; 2017 Jul; 33(7):499-502. PubMed ID: 28665896
[TBL] [Abstract][Full Text] [Related]
11. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
Avancini J; Maragno L; Santi CG; Criado PR
Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
[TBL] [Abstract][Full Text] [Related]
12. Preferential expression of CD134, an HHV-6 cellular receptor, on CD4T cells in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS).
Miyagawa F; Nakamura Y; Miyashita K; Iioka H; Himuro Y; Ogawa K; Nishimura C; Nishikawa M; Mitsui Y; Ito Y; Ommori R; Mori Y; Asada H
J Dermatol Sci; 2016 Aug; 83(2):151-4. PubMed ID: 27174092
[No Abstract] [Full Text] [Related]
13. Shock state: an unrecognized and underestimated presentation of drug reaction with eosinophilia and systemic symptoms.
Kimmoun A; Dubois E; Perez P; Barbaud A; Levy B
Shock; 2013 Nov; 40(5):387-91. PubMed ID: 24088996
[TBL] [Abstract][Full Text] [Related]
14. Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.
Myers AP; Watson TA; Strock SB
Pharmacotherapy; 2015 Mar; 35(3):e9-e12. PubMed ID: 25756365
[TBL] [Abstract][Full Text] [Related]
15. Skeletal myositis as the sole feature of relapsing drug reaction with eosinophilia and systemic symptoms syndrome.
Massey J; Kumar K; Ng K; Yun J; Fernando S
Ann Allergy Asthma Immunol; 2017 Jun; 118(6):726-728. PubMed ID: 28433575
[No Abstract] [Full Text] [Related]
16. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
Fernando SL
Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
[TBL] [Abstract][Full Text] [Related]
17. Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms.
Dorrell DN; Whitaker LF; Anderson KL; Strowd LC
J Am Acad Dermatol; 2019 Apr; 80(4):1159-1160. PubMed ID: 30403959
[No Abstract] [Full Text] [Related]
18. 62-Year-Old Man With Fever and Pruritic Rash.
Cochran BP; Kimbrough EO; Pagán RJ
Mayo Clin Proc; 2018 Nov; 93(11):1654-1658. PubMed ID: 30269943
[No Abstract] [Full Text] [Related]
19. Suspicion of fenofibrate-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report.
Safrano L; Bourneau-Martin D; Le Clech C; Chennebault JM; Jamet A; Drablier G; Lagarce L; Lainé-Cessac P
Therapie; 2014; 69(5):461-4. PubMed ID: 25269143
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-associated drug reaction with eosinophilia and systemic symptoms syndrome.
Young S; Ojaimi S; Dunckley H; Douglas MW; Kok J; Fulcher DA; Lin MW; Swaminathan S
Intern Med J; 2014 Jul; 44(7):694-6. PubMed ID: 25041771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
